If you liked this article you might like

FDA deals blow to Endo over Opana ER Pain Med
Welcome to the Small-Cap Biotech Mailbag!
Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo
Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking